scholarly journals Mechanistic Rationale and Clinical Efficacy of Hyperbaric Oxygen Therapy in Chronic Neuropathic Pain: An Evidence-Based Narrative Review

2021 ◽  
Vol 2021 ◽  
pp. 1-20
Author(s):  
Simone Schiavo ◽  
Julian DeBacker ◽  
Carine Djaiani ◽  
Anuj Bhatia ◽  
Marina Englesakis ◽  
...  

Background. Chronic neuropathic pain is a condition affecting an increasing proportion of the general population and its management requires a comprehensive, multidisciplinary program. A growing body of evidence supports the use of hyperbaric oxygen therapy (HBOT) in several chronic neuropathic pain conditions; however, its role and efficacy remain unclear. Purpose. To summarize current evidence for the mechanistic rationale of HBOT in chronic neuropathic pain conditions and to evaluate its clinical efficacy. Methods. This narrative review was conducted after searching the following databases (Medline, Embase, Cochrane, PsycINFO, the Web of Science, Scopus, ClinicalTrials. gov, WHO ICTRP, and ProQuest Digital Dissertation) from January 1946 to March 2020. Articles published in English that involved either animal or human studies with acute or chronic neuropathic pain evaluating any HBOT-related intervention were included. Results. A total of 2971 citations were identified. A total of 29 studies were included in this review. The mechanisms of action for HBOT use in neuropathic conditions included the primary effects of hyperoxia and edema resolution, as well as the secondary effects pertinent to the production of oxygen and nitrogen reactive species (serving as pain signaling molecules), nitric oxide-dependent release of opioid peptides, and reduction of inflammatory mediators. A robust evidence for HBOT use in the clinical setting was associated with chronic regional pain syndrome and chronic primary bladder pain syndrome. Some evidence supported its use for chronic secondary (peripheral) neuropathic pain including radiation-induced plexus neuropathies, postherpetic neuralgia, and trigeminal neuralgia. Conclusions. HBOT has been shown to have antinociceptive and analgesic effects in animal models of inflammatory, neuropathic, and chronic pain. Human studies demonstrated beneficial effects of HBOT in improving clinical outcomes such as pain scores, pain-related symptoms, and quality of life. A systematic methodology of HBOT application is necessary to confirm its safety and efficacy.

BMC Surgery ◽  
2013 ◽  
Vol 13 (Suppl 1) ◽  
pp. A26
Author(s):  
Luciano Grimaldi ◽  
Marco Ferretti ◽  
Stefano Reggio ◽  
Umberto Robustelli ◽  
Massimiliano Fabozzi ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-4 ◽  
Author(s):  
Rita Katznelson ◽  
Shira C. Segal ◽  
Hance Clarke

Hyperbaric oxygen therapy (HBOT) is a treatment that delivers 100% oxygen at increased atmospheric pressures. The efficacy of HBOT for treating pain has been described in various animal pain models and may have clinical efficacy in the treatment of human chronic pain syndromes. We present our experience with posttraumatic Complex Regional Pain Syndrome (CRPS) type 2 in a patient who underwent 15 sessions of HBOT. A 41-year-old male with one-year history of CRPS of left foot followed by left ankle fracture demonstrated less pain, decreased swelling, less allodynia, and improvement in skin color and range of motion of the lower limb after 3 weeks of HBOT. Patient was back to work for the first time in over a year. HBOT may be considered as a valuable therapeutic tool in the treatment of long-standing CRPS.


2017 ◽  
Vol 13 ◽  
pp. 174480691773025 ◽  
Author(s):  
Baisong Zhao ◽  
Erning He ◽  
Yongying Pan ◽  
Haiping Xu ◽  
Xingrong Song

2021 ◽  
Vol 11 (4) ◽  
pp. 0
Author(s):  
Tao Xue ◽  
Jia-Sheng Ding ◽  
Bing Li ◽  
De-Mao Cao ◽  
Gang Chen

2009 ◽  
Vol 101 (1) ◽  
pp. 77-80 ◽  
Author(s):  
Mehmet Zeki Kiralp ◽  
Gunalp Uzun ◽  
Omit Dincer ◽  
Ahmet Sen ◽  
Senol Yildiz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document